3.20 USD
↗ 0.07 (2.20%)PRE MARKET (AS OF 07:58 PM EDT)
Zentalis Pharmaceuticals, Inc. Common Stock
ZNTLNASDAQ • USD
Market: OPEN
Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $3.20. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 15, 2026.
Open?$3.51
High?$3.65
Low?$3.12
Prev. Close?$3.13
Volume?1.3M
Avg. Volume?1.0M
VWAP?$3.21
Rel. Volume?1.24x
Bid / Ask
Bid?$2.70 × 100
Ask?$3.76 × 100
Spread?$1.06
Midpoint?$3.23
Valuation & Ratios
Market Cap?296.3M
Shares Out?71.7M
Float?49.8M
Float %?69.5%
P/E Ratio?N/A
P/B Ratio?2.06
EPS?-$1.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
331.4M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?23
Short Sent.?70
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.32Distress
Confidence?52%Low
Short InterestHigh
Short % of Float?10.01%High
Short Interest?5.0M
Days to Cover?5.1
Free Float49.8M
Avg Daily Volume972.3K
Settlement Date2026-08-31
Financial Health
Current Ratio?4.82Strong
Quick Ratio?4.82Strong
Cash Ratio?0.66Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.06CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.8CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-97.2%WEAK▾
S&P3
ROA?-64.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-128129000
Enterprise Value?$271.5M
Fundamentals ratios updated end of day